Massimo Cappellini
About Massimo Cappellini
Massimo Cappellini is the Associate Director of GCP Clinical Quality Assurance at BeiGene, with over 15 years of experience in the biotechnology industry, specializing in oncology clinical trials and clinical data management.
Current Role at BeiGene
Massimo Cappellini currently serves as the Associate Director of GCP Clinical Quality Assurance at BeiGene. In this capacity, he focuses on maintaining and ensuring regulatory compliance and quality of clinical trials according to Good Clinical Practice (GCP) standards.
Experience at BeiGene
Before assuming his current role, Massimo Cappellini had an extensive tenure at BeiGene in various capacities. From 2018 to 2021, he worked as Senior Manager for Clinical Operations in Sydney, Australia. His earlier role at the company was Manager of Clinical Operations from 2017 to 2018. Throughout his tenure, he contributed to the oversight and management of clinical trials.
Previous Positions in the Biotechnology Industry
Massimo has accumulated significant experience working in leading roles at various companies within the biotechnology industry. Prior to BeiGene, he served as Clinical Research Manager at Sirtex Medical Limited from 2015 to 2017. Earlier, he was a Clinical Project Manager at PRA Health Sciences in 2015 and a Senior Clinical Research Associate at Quintiles from 2012 to 2014. He began his career as a Clinical Research Associate at PAREXEL and ICON plc, further honing his research and trial management skills.
Educational Background
Massimo Cappellini holds a Bachelor's Level Degree in Biotechnology from Università degli Studi di Milano-Bicocca, which he earned after four years of study from 2001 to 2005. His academic training in biotechnology provided a strong foundation for his career in clinical research and quality assurance.
Expertise in Clinical Trials and Data Management
With over 15 years of industry experience, Massimo Cappellini has developed a deep expertise in managing clinical trials, particularly in the oncology sector. He is skilled in utilizing Medidata, a cloud-based platform for clinical trials, and has a robust background in Electronic Data Capture (EDC) systems. His experience also includes ensuring the accuracy and integrity of clinical trial data.